Drug developer Array BioPharma (ARRY -12.3%) slides after pricing an 18M share secondary...

|About: Array BioPharma Inc. (ARRY)|By:, SA News Editor

Drug developer Array BioPharma (ARRY -12.3%) slides after pricing an 18M share secondary offering at $3.65 per share, a 10% discount to yesterday's close. The company had 95.4M shares outstanding as of October, which would make the sale nearly a 19% dilution to its float.